Alembic
Alembic Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Alembic
Start SIPAlembic Investment Rating
-
Master Rating:
-
Alembic (Nse) has an operating revenue of Rs. 127.24 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 68% is great, ROE of 9% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 8% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 74 which is a FAIR score but needs to improve its earnings, a RS Rating of 42 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|
Oper Rev Qtr Cr | 36 | 30 | 36 | 21 | 17 |
Operating Expenses Qtr Cr | 23 | 20 | 26 | 16 | 15 |
Operating Profit Qtr Cr | 13 | 10 | 10 | 5 | 3 |
Depreciation Qtr Cr | 2 | 2 | 2 | 2 | 1 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | -2 | 0 | 7 | 0 | 1 |
Net Profit Qtr Cr | 4 | 10 | 61 | 4 | 5 |
Alembic Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹66.45
- 50 Day
- ₹64.97
- 100 Day
- ₹65.48
- 200 Day
- ₹68.63
- 20 Day
- ₹66.97
- 50 Day
- ₹63.14
- 100 Day
- ₹64.82
- 200 Day
- ₹68.18
Alembic Resistance and Support
Resistance | |
---|---|
First Resistance | ₹69.1 |
Second Resistance | ₹69.8 |
Third Resistance | ₹70.66 |
RSI | 63.46 |
MFI | 62.48 |
MACD Single Line | 1.29 |
MACD | 1.14 |
Support | |
---|---|
First Resistance | ₹67.55 |
Second Resistance | ₹66.7 |
Third Resistance | ₹66 |
Alembic Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 158,835 | 7,582,783 | 47.74 |
Week | 158,077 | 9,091,020 | 57.51 |
1 Month | 369,641 | 13,998,306 | 37.87 |
6 Month | 211,032 | 10,110,553 | 47.91 |
Alembic Result Highlights
Alembic Synopsis
NSE-Medical-Diversified
Alembic Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 123.16 Cr. and Equity Capital is Rs. 51.36 Cr. for the Year ended 31/03/2023. Alembic Ltd. is a Public Limited Listed company incorporated on 30/07/1907 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L26100GJ1907PLC000033 and registration number is 000033.Market Cap | 1,763 |
Sales | 123 |
Shares in Float | 7.45 |
No of funds | 36 |
Yield | 3.22 |
Book Value | 2.12 |
U/D Vol ratio | 1.6 |
LTDebt / Equity | |
Alpha | -0.02 |
Beta | 1.23 |
Alembic
Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
---|---|---|---|---|
Promoters | 70.88% | 70.88% | 70.88% | 70.88% |
Mutual Funds | 3.89% | 3.89% | 4.07% | 4.24% |
Foreign Portfolio Investors | 0.7% | 0.82% | 0.83% | 1.08% |
Financial Institutions/ Banks | 0.05% | 0.05% | 0.05% | 0.05% |
Individual Investors | 19.52% | 19.47% | 19.4% | 19.07% |
Others | 4.96% | 4.89% | 4.77% | 4.68% |
Alembic Management
Name | Designation |
---|---|
Mr. Chirayu Amin | Chairman |
Mrs. Malika Amin | Managing Director & CEO |
Mr. Udit Amin | Director |
Mr. Abhijit Joshi | Director |
Mr. C P Buch | Independent Director |
Mrs. Rati Desai | Independent Director |
Mr. Sameer Khera | Independent Director |
Mr. Mayank Amin | Independent Director |
Alembic Forecast
Price Estimates
Alembic FAQs
What is Share Price of Alembic ?
Alembic share price is ₹68 As on 05 June, 2023 | 14:35
What is the Market Cap of Alembic ?
The Market Cap of Alembic is ₹1762.8 Cr As on 05 June, 2023 | 14:35
What is the P/E ratio of Alembic ?
The P/E ratio of Alembic is 9.2 As on 05 June, 2023 | 14:35
What is the PB ratio of Alembic ?
The PB ratio of Alembic is 0.8 As on 05 June, 2023 | 14:35